Php243 - Do Disease Severity and/or Quality of Clinical Data Influence Pricing Policy in France? An Analysis on Orphan Drugs and Blood Cancers Treatments

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1137